Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections
- PMID: 21981983
- DOI: 10.1016/j.jcv.2011.09.011
Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections
Abstract
Background: The current algorithm for HIV diagnosis in the US involves screening with an immunoassay (IA) and supplemental testing with Western blot (WB) or immunofluorescence assay. Because of existence of more sensitive and specific FDA-approved assays that would also reduce the cost and turn-around time of testing compared to WB, several alternative algorithms have been evaluated. Recently, an alternative algorithm using a sensitive 3rd or 4th generation IA followed by an HIV-1 and HIV-2 discriminatory supplemental test on the initial IA-positive specimens was proposed. Concordant positive results indicate HIV-positive specimens and discordant results are resolved by nucleic acid amplification testing (NAAT).
Objectives: To evaluate the sensitivity of assays during acute HIV infection and the performance of the current and an alternative algorithm using samples from HIV-1 seroconversion panels and persons with established HIV infections.
Study design: To evaluate the algorithms in early infections, 26 HIV-1 seroconverters from the US were tested with three 3rd generation and one 4th generation IA, six rapid tests (RTs), one NAAT, and WB. Sensitivity and specificity of the algorithms were calculated by testing an additional 416 HIV-positive and 414 uninfected control samples with one 3rd generation and one 4th generation IA, four RTs, one NAAT, and WB.
Results: The individual assays evaluated became positive 5 (RT) to 26 days (NAAT) before WB was positive. Among seroconverters, the alternative algorithm detected significantly more infections than the current algorithm (103-134 versus 56, p<0.0001). Furthermore, the use of a 4th generation IA instead of a 3rd generation assay as the screen resulted in significantly higher detection of acute infections (p<0.0001). In contrast, the algorithms performed equally among specimens from established HIV-1 infections.
Conclusions: This study demonstrated improved sensitivity of the alternative algorithm for detecting acute HIV-1 infections, while maintaining the ability to accurately detect established HIV-1 infections. Early detection is important as individuals can be highly infectious during acute infection. In addition, the alternative algorithm should reduce turn-around time by using a RT as the supplemental test has the potential to increase the number of test results returned.
Published by Elsevier B.V.
Similar articles
-
Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.J Clin Virol. 2011 Dec;52 Suppl 1:S45-9. doi: 10.1016/j.jcv.2011.09.026. Epub 2011 Oct 12. J Clin Virol. 2011. PMID: 21995934
-
Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population.J Clin Virol. 2011 Dec;52 Suppl 1:S5-10. doi: 10.1016/j.jcv.2011.09.013. Epub 2011 Oct 22. J Clin Virol. 2011. PMID: 22019251
-
Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.J Clin Virol. 2011 Dec;52 Suppl 1:S41-4. doi: 10.1016/j.jcv.2011.09.017. Epub 2011 Oct 12. J Clin Virol. 2011. PMID: 21995935
-
Assays for the detection of recent infections with human immunodeficiency virus type 1.Euro Surveill. 2008 Sep 4;13(36):18966. Euro Surveill. 2008. PMID: 18775293 Review.
-
Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing.Future Microbiol. 2009 Oct;4(8):963-82. doi: 10.2217/fmb.09.77. Future Microbiol. 2009. PMID: 19824789 Review.
Cited by
-
HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern.Blood. 2020 Sep 10;136(11):1351-1358. doi: 10.1182/blood.2020006890. Blood. 2020. PMID: 32645148 Free PMC article.
-
Vaccine-Induced Seroreactivity Impacts the Accuracy of HIV Testing Algorithms in Sub-Saharan Africa: An Exploratory Study.Vaccines (Basel). 2022 Jul 1;10(7):1062. doi: 10.3390/vaccines10071062. Vaccines (Basel). 2022. PMID: 35891226 Free PMC article.
-
Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.J Clin Virol. 2017 Jun;91:95-100. doi: 10.1016/j.jcv.2017.03.019. Epub 2017 Mar 24. J Clin Virol. 2017. PMID: 28372891 Free PMC article.
-
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.J Virus Erad. 2018 Jul 1;4(3):143-159. J Virus Erad. 2018. PMID: 30050676 Free PMC article.
-
Clinical application evaluation of two fourth-generation human immunodeficiency virus (HIV) screening assays in West China Hospital.J Clin Lab Anal. 2015 Mar;29(2):146-52. doi: 10.1002/jcla.21743. Epub 2014 May 5. J Clin Lab Anal. 2015. PMID: 24797498 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical